| Literature DB >> 31146338 |
Rebecca Singer1, Karen Zwi2,3, Robert Menzies4.
Abstract
Background: Aboriginal Australian children have higher rates of mortality at younger ages than non-Aboriginal Australian children. We aimed to (i) calculate the case fatality rate (CFR) for Aboriginal and non-Aboriginal children admitted to children's hospitals in New South Wales (NSW) and (ii) identify predictors of CFR.Entities:
Keywords: aboriginal; case fatality rate; children; indigenous; infants; mortality
Mesh:
Year: 2019 PMID: 31146338 PMCID: PMC6603740 DOI: 10.3390/ijerph16111893
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Demographics and clinical characteristics of admissions.
| Clinical Characteristics | Total Admitted Children (Range) | Aboriginal Admissions (Range) | Non-Aboriginal Admissions (Range) | |
|---|---|---|---|---|
| Length of Stay (Median, Days) | 1.00 (1, 826) | 1.00 (1, 341) | 1.00 (1, 826) | <0.001 |
| Total (% of Total) | Aboriginal Admissions (% of Deaths) | Non-Aboriginal Admissions (% of Total) | ||
|
| <0.001 | |||
| Neonate (0–28 days) | 6273 (2.5%) | 237 (3.8%) | 6033 (2.5%) | |
| Infant (29 days–23 months) | 62,337 (25.3%) | 2072 (27.2%) | 60,213 (25.2%) | |
| Young Child (2–5 years) | 70,080 (28.4%) | 1837 (24.1%) | 68,192 (28.6%) | |
| Child (6–12 years) | 69,017 (28.0%) | 2056 (27%) | 66,912 (28.0%) | |
| Adolescent (13–17 years) | 37,380 (15.2%) | 1393 (18.3%) | 36,039 (15.1%) | |
| Adult (18–25 years) | 1273 (0.5%) | 28 (0.4%) | 1274 (0.5%) | |
|
| <0.001 | |||
| Male | 140,796 (57.1%) | 4136 (54.3%) | 136,616 (57.2%) | |
| Female | 105,567 (42.9%) | 3487 (45.7%) | 102,047 (42.8%) | |
|
| ||||
| Identify as Aboriginal and/or Torres Strait Islander | 7625 (3.1%) | |||
| Do not identify as Aboriginal and/or Torres Strait Islander | 238,738 (96.9%) | |||
|
| <0.001 | |||
| Very Remote Australia | 268 (0.1%) | 96 (1.3%) | 172 (0.1%) | |
| Remote Australia | 700 (0.3%) | 248 (3.3%) | 448 (0.2%) | |
| Outer Regional Australia | 5390 (2.2%) | 935 (12.3%) | 4447 (1.9%) | |
| Inner Regional Australia | 20,324 (8.2%) | 1415 (18.6%) | 17,982 (7.6%) | |
| Major Cities of Australia | 217,804 (88.4%) | 4919 (64.6%) | 213,746 (90.3%) | |
| Other/Overseas | 1877 (0.8%) | 12 (0.2%) | 1943 (0.8%) | |
|
| <0.001 | |||
| Low (<850) | 9274 (3.8%) | 658 (8.6%) | 8605 (3.6%) | |
| Med (850–1000) | 105,348 (42.8%) | 5112 (67.1%) | 100,054 (41.9%) | |
| High (>1000) | 129,682 (52.7%) | 1814 (23.8%) | 127,896 (53.6%) | |
| N/A (e.g., overseas) | 1879 (0.8%) | 39 (0.5%) | 2108 (0.9%) | |
|
| <0.001 | |||
| Emergency | 111,709 (45.3%) | 2800 (36.7%) | 108,882 (45.6%) | |
| Non-Emergency | 134,621 (54.7%) | 4823 (63.3%) | 129,781 (54.4%) | |
|
| 0.002 | |||
| Yes | 543 (0.2%) | 29 (0.38%) | 513 (0.2%) | |
| No | 246,820 (99.8%) | 7594 (99.6%) | 238,150 (99.8%) | |
|
| <0.001 | |||
| No | 197,284 (80.1%) | 6247 (81.9%) | 191,015 (80%) | |
| Yes | 49,028 (19.9%) | 1376 (18.1%) | 47,648 (20%) | |
|
| <0.001 | |||
| No | 234,333 (95.1%) | 7073 (92.8%) | 227,234 (95.2%) | |
| Yes | 11,979 (4.9%) | 550 (7.2%) | 11,429 (4.8%) | |
|
| ||||
| Infection | 10,681 (4.3%) | 248 (3.3%) | 10,433 (4.4%) | <0.001 |
| Neoplasm/Blood/Immune | 25,313 (10.3%) | 548 (7.2%) | 24,763 (10.4%) | <0.001 |
| Endocrine/Nutritional/Metabolic | 8208 (3.3%) | 377 (4.9%) | 7831 (3.3%) | <0.001 |
| Mental & Behavioural | 2603 (1.1%) | 92 (1.2%) | 2511 (1.1%) | 0.193 |
| Nervous System | 14,163 (5.8%) | 554 (7.3%) | 13,608 (5.7%) | <0.001 |
| Eye, ear & adnexa | 7528 (3.1%) | 343 (4.5%) | 7183 (3.0%) | <0.001 |
| Circulatory | 2679 (1.1%) | 90 (1.2%) | 2589 (1.1%) | 0.427 |
| Respiratory | 28,715 (11.7%) | 782 (10.3%) | 27,930 (11.7%) | <0.001 |
| Digestive | 19,856 (8.1%) | 487 (6.4%) | 19,366 (8.1%) | <0.001 |
| Skin | 7064 (2.9%) | 236 (3.1%) | 6828 (2.9%) | 0.226 |
| Musculoskeletal | 9561 (3.9%) | 267 (3.5%) | 9293 (3.9%) | 0.082 |
| Genitourinary | 9724 (3.9%) | 288 (3.8%) | 9435 (4.0%) | 0.439 |
| Pregnancy & Childbirth | 5 (<1%) | 1 (<0.1%) | 3 (<0.1%) | 0.011 |
| Perinatal | 2503 (1%) | 71 (0.9%) | 2432 (1.0%) | 0.453 |
| Congenital & chromosomal | 22,726 (9.2%) | 927 (12.2%) | 21,794 (9.1%) | <0.001 |
| Other symptoms | 21,234 (8.6%) | 474 (6.2%) | 20,757 (8.7%) | <0.001 |
| Injury/poisoning | 31,918 (13%) | 1003 (13.2%) | 30,914 (13.0%) | 0.601 |
| Not Otherwise Specified | 21,831 (8.9%) | 835 (11.0%) | 20,993 (8.8%) | <0.001 |
1 Aboriginal compared to non-Aboriginal Admissions.
Demographic and clinical characteristics of deaths.
| Clinical Characteristics | In-Hospital Deaths (Range) | Aboriginal Deaths (Range) | Non-Aboriginal Deaths (Range) | CFR ^ Ratio (95% CI) | |
|---|---|---|---|---|---|
| Median Length of Stay (Days) | 5.00 (1, 404) | 3.00 (1, 241) | 5.00 (1, 404) | 0.568 | |
| Deaths (CFR) | Aboriginal Deaths (CFR) | Non-Aboriginal Deaths (CFR) | |||
|
| 0.576 | ||||
| Neonate (0–28 days) | 135 (2.11%) | 8 (3.38%) | 127 (2.11%) | 1.6 (0.79–3.24) | |
| Infant (1 to 23 months) | 148 (0.23%) | 10 (0.48%) | 138 (0.23%) |
| |
| Young Child (2–5 years) | 99 (0.14%) | 3 (0.16%) | 96 (0.14%) | 1.2 (0.37 | |
| Child (6–12 years) | 78 (0.11%) | 2 (0.10%) | 76 (0.11%) | 0.9 (0.21 | |
| Adolescent (13–17 years) | 80 (0.21%) | 6 (0.43%) | 74 (0.21%) | 2.1 (0.91 | |
| Adult (18 years or more) | 3 (0.24%) | 0 (0.0%) | 3 (0.24%) | ||
|
| 0.846 | ||||
| Male | 309 (0.23%) | 16 (0.39%) | 293 (0.21%) |
| |
| Female | 234 (0.22%) | 13 (0.37%) | 221 (0.22%) | 1.7 (0.98 | |
|
|
| ||||
| Aboriginal | 29 (0.38%) | ||||
| Non-Aboriginal | 514 (0.22%) | ||||
|
| <0.001 | ||||
| Very Remote Australia | 2 (0.75%) | 1 (1.04%) | 1 (0.58%) | 1.8 (0.11 | |
| Remote Australia | 4 (0.57%) | 3 (1.21%) | 1 (0.22%) | 5.4 (0.57 | |
| Outer Regional Australia | 17 (0.32%) | 8 (0.86%) | 9 (0.20%) |
| |
| Inner Regional Australia | 50 (0.25%) | 4 (0.28%) | 46 (0.26%) | 1.1 (0.40 | |
| Major Cities of Australia | 459 (0.21%) | 13 (0.26%) | 446 (0.21%) | 1.3 (0.73 | |
| Other/Overseas | 11 (0.59%) | 0 (0.0%) | 11 (0.57%) | ||
|
| 0.027 | ||||
| Low (<850) | 29 (0.31%) | 3 (0.46%) | 26 (0.30%) | 1.5 (0.46 | |
| Med (850–1000) | 277 (0.26%) | 21 (0.41%) | 256 (0.26%) |
| |
| High (>1000) | 225 (0.17%) | 5 (0.28%) | 220 (0.17%) | 1.6 (0.66 | |
| N/A (e.g., overseas) | 12 (0.64%) | 0 (0.0%) | 12 (0.57%) | ||
|
| 0.030 | ||||
| Emergency | 311 (0.28%) | 11 (0.39%) | 300 (0.28%) | 1.4 (0.78 | |
| Non-Emergency | 232 (0.17%) | 18 (0.37%) | 214 (0.16%) |
| |
|
| 0.409 | ||||
| No | 510 (0.26%) | 26 (0.42%) | 484 (0.25%) |
| |
| Yes | 33 (0.07%) | 3 (0.22%) | 30 (0.06%) |
| |
|
| 1.000 | ||||
| No | 524 (0.22%) | 28 (0.40%) | 496 (0.22%) |
| |
| Yes | 19 (0.16%) | 1 (0.18%) | 18 (0.16%) | 1.2 (0.15 | |
|
| |||||
| Infection | 27 (0.25%) | 1 (0.40%) | 26 (0.25%) | 1.000 | 1.6 (0.22 |
| Neoplasm/Blood/Immune | 83 (0.33%) | 2 (0.36%) | 81 (0.33%) | 0.289 | 1.1 (0.27 |
| Endocrine/Nutritional/Metabolic | 11 (0.13%) | 0 (0.0%) | 11 (0.14%) | 1.000 | |
| Mental & Behavioural | 0 (0%) | 0 (0.0%) | 0 (0%) | ||
| Nervous system | 42 (0.30%) | 2 (0.36%) | 40 (0.29%) | 1.000 | 1.2 (0.30 |
| Eye, ear & adnexa | 0 (0%) | 0 (0.0%) | 0 (0%) | ||
| Circulatory | 74 (2.76%) | 7 (7.78%) | 67 (2.59%) | 0.003 |
|
| Respiratory | 37 (0.13%) | 1 (0.13%) | 36 (0.13%) | 0.712 | 1.0 (0.13 |
| Digestive | 11 (0.06%) | 0 (0.0%) | 11 (0.06%) | 1.000 | |
| Skin | 0 (0%) | 0 (0.0%) | 0 (0%) | ||
| Musculoskeletal | 3 (0.03%) | 0 (0.0%) | 3 (0.03%) | 1.000 | |
| Genitourinary | 2 (0.02%) | 1 (0.35%) | 1 (0.01%) | 0.104 |
|
| Pregnancy & Childbirth | 0 (0%) | 0 (0.0%) | 0 (0%) | ||
| Perinatal | 35 (1.40%) | 5 (7.04%) | 30 (1.23%) | <0.001 |
|
| Congenital & chromosomal | 99 (0.44%) | 4 (0.43%) | 95 (0.44%) | 0.525 | 1.0 (0.36 |
| Other symptoms | 18 (0.08%) | 1 (0.21%) | 17 (0.08%) | 1.000 | 2.6 (0.34 |
| Injury/poisoning | 63 (0.20%) | 4 (0.40%) | 59 (0.19%) | 0.763 | 2.1 (0.76 |
| Not Otherwise Specified | 38 (0.17%) | 1 (0.12%) | 37 (0.18%) | 0.712 | 0.7 (0.09 |
# Aboriginal compared with Non-Aboriginal; * and bold denotes significant finding; ^ case fatality rate; ° no reference category available as compared against all other admissions (e.g., infection diagnosis compared with non-infection diagnoses).
Factors associated with death (multivariate logics regression) in all children.
| Characteristic | OR | 95% CI | ||
|---|---|---|---|---|
| Length of Stay | Days | 1.014 | 1.012 | <0.001 |
| Age Group (c.f. neonates) | <0.001 | |||
| Neonates (0 | ref | |||
| Infant (1 | 0.124 | 0.097 | <0.001 | |
| Young Child (2 | 0.071 | 0.054 | <0.001 | |
| Child (6 | 0.046 | 0.042 | <0.001 | |
| Adolescent (13 | 0.105 | 0.078 | <0.001 | |
| Adult (>18y) | 0.140 | 0.044 | 0.001 | |
| Aboriginality | Aboriginal | 1.727 | 1.178 | 0.005 |
| Non-Aboriginal | ref | |||
| Emergency Admission | Emergency Admission | 1.940 | 1.619 | <0.001 |
| Non-Emergency Admission | ref | |||
| Main Diagnostic Code | Neoplasm/Blood/Immune | 2.765 | 2.140 | <0.001 |
| Circulatory | 17.158 | 13.190 | <0.001 | |
| Digestive | 0.328 | 0.174 | 0.001 | |
| Musculoskeletal | 0.257 | 0.082 | 0.020 | |
| Other Symptoms | 0.398 | 0.247 | <0.001 | |